![](https://dbtnews.com/wp-content/uploads/2020/01/Image-61.png)
Oppenheimer slashes price target on Xeris Biopharma Holdings Inc [XERS] – find out why.
Xeris Biopharma Holdings Inc [NASDAQ: XERS] price surged by 8.58 percent to reach at $0.19. The one-year XERS stock forecast points to a potential upside of 48.91. The average equity rating for XERS stock is currently 1.00, trading closer to a bullish pattern in the